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Abstract
Background: There is growing evidence that damage to spermatozoa by reactive oxygen species
(ROS) play a key role in male infertility. The aim of the present study was to assess seminal plasma
levels of total antioxidant capacity (TAC), free 8-Isoprostane and activities of catalase and
superoxide dismutase (SOD) in men with asthenozoospermia, asthenoteratozoospermia and
oligoasthenoteratozoospermia compared with normozoospermic males.
Methods: The patients consisted of 46 men with seminal parameters abnormalities. The patients
were grouped into asthenozoospermic (n = 15), asthenoteratozoospermic (n = 16) and
oligoasthenoteratozoospermic (n = 15). The control group consisted of 16 healthy males with
normozoospermia. Catalase activity was measured by Aebi spectrophotometeric method. Levels
of TAC and SOD were measured by commercially available colorimetric assays. Level of free 8-
Isoprostane was assessed by commercially available enzyme immunoassay (EIA) method.
Differences between groups were assessed using Mann-Whitney U test and Kruskal-Wallis test.
Coefficients of correlation were calculated using Spearman's correlation analysis. All hypothesis
tests were two-tailed with statistical significance assessed at the p value < 0.05 level with 95%
confidence intervals
Results: Levels of catalase and TAC were significantly lower in patients than the control group.
No significant changes were seen in SOD activities. Levels of free 8-Isoprostane were significantly
higher in patients than the control group. Furthermore, asthenozoospermic,
asthenoteratozoospermic and oligoasthenoteratozoospermic groups had significantly lower values
of catalase activity and TAC when compared to normozoospermic males. Levels of free 8-
Isoprostane were significantly higher in all patients subgroups than the control group. Levels of
catalase and TAC were positively correlated with sperm motility and morphology. Free 8-
Isoprostane levels showed an inverse correlation with sperm motility and morphology.
Conclusion: Decreasing seminal plasma antioxidants levels, especially catalase and TAC, could
have significant role in etiology of impaired sperm function. Measurement of 8-Isoprostane may be
used as a specific biomarker for assessing oxidative stress on sperm.
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In the etiology of male infertility, there is growing evi-
dence that damage to spermatozoa by reactive oxygen spe-
cies (ROS) play a key role [1,2]. Spermatozoa contain
large quantities of polyunsaturated fatty acids (PUFA).
Therefore, they are susceptible to ROS-induced damage. It
has been suggested that ROS induce membrane lipid per-
oxidation in sperm [3-5]. The seminal plasma is well
endowed with an array of antioxidants that act as free rad-
ical scavengers to protect spermatozoa against oxidative
stress. Seminal plasma contains a number of enzymatic
antioxidants such as superoxide dismutase (SOD) and
catalase. In addition, it contains a variety of non-enzy-
matic antioxidants [6-9].
The findings on the seminal plasma catalase and SOD
activities and total antioxidant capacity (TAC) are contro-
versial. Sanocka et al study showed statistically significant
change in activity of SOD in infertile men compared to
normozoospermic samples. They also observed that the
SOD activity exceeds values obtained for normozoosper-
mic samples only in oligozoospermic males [10]. In
another study Sanocka et al investigated activities of SOD
and catalase in men with asthenozoospermia, teratozo-
ospermia and oligozoospermia compared to normo-
zoospermic males. Their study showed a significant
elevation in intracellular activity of SOD and decreasing
in catalase activity in infertile samples [11]. Zini et al study
showed that seminal plasma activity of SOD in infertile
men is significantly grater than in fertile men while cata-
lase activity is not different between these groups [12].
The study conducted by Siciliano et al showed seminal
plasma enzymatic (catalase and SOD) and nonenzymatic
(TAC) antioxidant capacities do not alter in the astheno-
zoospermic specimens, whereas SOD activity is lower in
oligoasthenozoospermic samples than normozoospermic
males [13]. Hsieh et al investigation showed that there is
not a significant difference in seminal plasma or sperm
SOD activity between normozoospermic and oligo- or
asthenozoospermic males [14]. This group also observed
that activities of SOD do not correlate significantly with
sperm motility and concentration. Tkaczuk-Wlach et al
observed that whole semen SOD activity is higher in men
with oligoszoospermia than those with normozoosper-
mia [15]. Koca et al study showed that seminal plasma
TAC in infertile asthenozoospermic and asthenoteratozo-
ospermic males is lower than fertile men [16]. They also
observed a positive correlation between seminal plasma
TAC and sperm motility.
Available data on the impact of oxidative stress on sperm
are based on the measurement of seminal plasma and
sperm levels of malondialdehyde (MDA) by the thiobar-
bituric acid-reacting substance (TBARS) assay [17-25].
Recently, it has been shown that 8-Isoprostane is a spe-
cific, chemically stable, and quantitative marker of oxida-
tive stress in vivo. 8-Isoprostane is formed in situ in cell
membranes; following free radical attack on the arachi-
donic acid [26-28].
The aim of the present study was to assess seminal plasma
levels of TAC and free 8-Isoprostane and activities of cata-
lase and SOD in men with asthenozoospermia, asthenot-
eratozoospermia and oligoasthenoteratozoospermia
compared to normozoospermic males.
Methods
Semen Samples
A case-control study was designed. Following Institu-
tional Review Board approval, the semen samples were
collected from the case and the control groups. All speci-
mens were collected into sterile plastic containers by mas-
turbation after an abstinence period of 3–5 days, and were
analyzed within 1 h of collection. After allowing at least
30 min for liquefaction to occur, semen analysis was per-
formed to measure sperm concentration, sperm motility
and sperm morphology using Sperm Quality Analyzer IIC
(SQA IIC, United Medical Systems Inc, Santa Ana, CA,
USA) [29,30]. Samples with a leukocyte concentration
>106/ml of ejaculate and specimens with hyperviscosity
were excluded from this study. The criteria for sperm nor-
mality were as follows: sperm concentration ≥ 20 × 106/
ml of ejaculate, sperm motility ≥ 50% and normal sperm
morphology ≥ 30% [13,29,30]. The case group consisted
of men with asthenozoospermia (n = 15) (age 31.33 ±
4.84 yr), asthenoteratozoospermia (n = 16) (age 34.31 ±
5.20 yr) and oligoasthenoteratozoospermia (n = 15) (age
35.75 ± 5.33 yr). The control group consisted of 16 men
with normal semen parameters and proven fertility (age
32.06 ± 3.91 yr). Liquefied semen samples were centri-
fuged at 10000 g for 10 minutes [12,31]. The supernatant
seminal plasma was then frozen at -80°C until examina-
tion.
TAC measurement
TAC was measured by colorimetric assay [32,33]. We used
commercially available colorimetric method (Randox
Laboratories Ltd, UK). The frozen seminal plasma was
thawed by placing the vials in a water bath at 37°C for 20
minutes and immediately assessed for its antioxidant
capacity. Twenty microliters of seminal plasma was added
to 1 mL of the reconstituted chromogen, 2, 2'-Azino-di-
(3-ethylbenzthiazoline sulphonate) (ABTS)-metmy-
oglobin (10 mL vial with 10 mL of phosphate-buffered
saline buffer). Twenty microliters of Trolox (6-hydroxyl-2,
5, 7, 8-tetramethylchroman-2-carboxylic acid) at a con-
centration of 1.71 mmol/L was used as the standard.
Whereas 20 µl of deionized water was used as a blank.
One milliliter of chromogen was added to the standard
and blank samples. With spectrophotometer adjusted at aPage 2 of 6
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read. Two hundred microliters of H2O2 (250 µmol/L) was
then added to all tubes, and absorbance (A2) was read
exactly after 3 minutes. The difference between A2 and A1
(∆A) was calculated. The TAC of the sample was then cal-
culated by the following formula: TAC = Concentration of
the Standard × (∆A Blank - ∆A Sample)/(∆A Blank - ∆A
Standard). The results were expressed as mM.
SOD activity measurement
SOD activity was measured by colorimetric assay [12,31].
We used commercially available colorimetric method
(Randox Laboratories Ltd, UK). This method employs
xanthine and xanthine oxidase to generate superoxide
radicals which reacts with 2-(4-iodophenyl)-3-(4-nitroph-
enol)-5-phenyltetrazoliumchloride (I.N.T) to form red
formazan dye. The SOD activity is then measured by the
degree of inhibition of this reaction. One unit of SOD
inhibits reduction of INT by 50% under the conditions of
the assay. After thawing, the seminal plasma was diluted
30-fold with 10 mM phosphate buffer, pH 7.0. Assay was
performed at 37°C. Phosphate buffer was used as blank.
Mixed substrate and xanthine oxidase were added into
standards and sample tubes and vortexed well. With spec-
trophotometer adjusted at a wavelength of 505 nm, the
initial absorbance (A1) was read. Final absorbance (A2)
was read exactly after 3 minutes. Percentages of inhibition
of standards and samples were calculated. The SOD activ-
ity was measured using calibration curve of percentage
inhibition for each standard against Log10 of standards
and SOD activity was expressed as U/ml.
Catalase activity measurement
Catalase activity was estimated by the method of Aebi
[34]. Catalase can degrade hydrogen peroxide which can
be measured directly by the decrease in the absorbance at
240 nm. The hydrogen peroxide was diluted with phos-
phate buffer pH 7.0 and its initial absorbance was
adjusted between 0.5 to 0.6 absorbance unit at 240 nm.
The decrease in the absorbance was measured. One unit of
catalase activity was defined as the amount of catalase
which absorbed in 30 sec at 25°C. The catalase activity
was then calculated from the change in absorbance and
finally expressed as U/ml.
8-Isoprostane assessment
We assessed free form of 8-Isoprostane and only the frac-
tion shedded to seminal plasma from cell membranes.
Free 8-Isoprostane purification
Free 8-Isoprostane was purified by affinity chromatogra-
phy method [35]. We used commercially available affinity
column (Cayman Chemical, Ann Arbor, MI, USA). All
samples were centrifuged at 15000 g for isolating of par-
ticulates and precipitates. Then the supernatant was
diluted 1:5 with column buffer and applied to the col-
umn. Other procedures were according to the instructions
provided by the manufacturer. The ethanol washed 8-Iso-
prostane stored at -80°C until measurement.
Free 8-Isoprostane measurement
At first, the elution solution was evaporated to dryness
using a vacuum centrifugation. Then, the concentration of
free 8-Isoprostane was measured by enzyme immu-
noassay (EIA) method [35]. We used commercially avail-
able EIA method (Cayman Chemical, Ann Arbor, MI,
USA). The procedure for the EIA was according to the
instructions provided by the manufacturer. The sample
volume that used was 50 µl. Absorbance was measured at
a wavelength of 405 nm using enzyme-linked immuno-
sorbent assay (ELISA) reader (STAT FAX 2100, USA). The
levels of free 8-Isoprostane were presented as ng/ml. The
intra-assay coefficient of variation was <10%.
Statistical analysis
Differences between groups were assessed using Mann-
Whitney U test and Kruskal-Wallis test. Coefficients of
correlation were calculated using Spearman's correlation
analysis. All hypothesis tests were two-tailed with statisti-
cal significance assessed at the p value < 0.05 level with
95% confidence intervals. The data were expressed as the
mean ± SEM. Statistical computations were calculated
using SPSS 11.5 for windows software (SPSS Inc, Chicago,
IL, USA).
Results
Seminal parameters of the subjects are reported in Table 1.
Table 2 shows comparison of seminal plasma levels of
free 8-Isoprostane and TAC and activities of catalase and
SOD between patients and control groups. Levels of cata-
lase and TAC were significantly lower in patients than the
control group. No significant changes were seen in SOD
activities. Seminal plasma levels of free 8-Isoprostane
were significantly higher in patients than the control
group. Table 3 shows seminal plasma levels of free 8-Iso-
prostane and TAC and activities of catalase and SOD in
subgroups of the patients compared to normozoospermic
subjects. Asthenozoospermic, asthenoteratozoospermic
and oligoasthenoteratozoospermic males had significant
lower values of catalase and TAC compared with normo-
zoospermic males. Levels of free 8-Isoprostane were sig-
nificantly higher in all patients than the control group.
Then, we examined the correlation between seminal
parameters and seminal plasma levels of 8-Isoprostane,
TAC, SOD and catalase in total case group. Levels of TAC
showed a positive correlation with sperm motility (r =
0.45, p < 0.05) and morphology (r = 0.45, p < 0.05). We
also observed a direct correlation between catalase activity
and sperm concentration (r = 0.41, p < 0.05), spermPage 3 of 6
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0.42, p < 0.05). Seminal plasma levels of free 8-Isopros-
tane showed an inverse correlation with sperm motility (r
= -0.26, p < 0.05) and sperm morphology (r = -0.27, p <
0.05). Levels of SOD did not show any correlation with
seminal parameters.
Discussion
The most relevant findings of this study were (i) signifi-
cant elevation of seminal plasma levels of free 8-Isopros-
tane and decreasing of catalase and TAC levels in
asthenozoospermic, asthenoteratozoospermic, oligoas-
thenoteratozoospermic samples compared with normo-
zoospermic men (ii) both catalase and TAC showed a
positive correlation with sperm motility and morphology
while an inverse correlation was seen with free 8-Isopros-
tane levels.
Our findings about activities of SOD were contradicted
the results of Sanocka et al [10,11]. Our findings confirm
Sanocka et al results about catalase activity in infertile men
[11]. Siciliano et al. evaluated antioxidant capacity of sem-
inal plasma in asthenozoospermic and oligoastheno-
zoospermic specimens with normal viscosity and
hyperviscosity [13]. Their study showed that in semen
with normal viscosity levels of catalase, SOD and TAC do
not alter in asthenozoospermic specimens compared with
normozoospermic men. They observed that SOD activity
declines in oligoasthenozoospermic males. In contrast to
Siciliano et al., we observed a significant decrease in cata-
lase activity and TAC in men with asthenozoospermia
compared to normozoospermic men. Our finding about
SOD activity in asthenozoospermic men was similar to
Siciliano et al study. In another study, Hsieh et al evalu-
ated SOD activities in seminal plasma and spermatozoa in
infertile men with normozoospermia and oligoastheno-
zoospermia [14]. They observed that SOD activities of
seminal plasma and sperm in both groups are nonsignifi-
cantly different. Hsieh et al also observed that SOD activ-
ities of seminal plasma and sperm are positively but
nonsignificantly correlated with sperm motility and con-
centration. Our results about the SOD activity of the sem-
inal plasma in oligoasthenozoospermic men were similar
to Hsieh et al study. Koca et al evaluated TAC in infertile
asthenozoospermic and asthenoteratozoospermic men
compared to normozoosperic fertile men [16]. Their
study showed that asthenozoospermic and asthenoterato-
zoospermic males have significantly lower mean TAC
value than the control group. Koca et al study also showed
that TAC correlates positively to sperm motility. We also
observed these findings. Tkaczuk-Wlach et al evaluated
activity of SOD in the whole semen of patients with oligo-
zoospermia compared to patients with normozoospermia
[15]. Their study showed that oligozoospermia males
have significantly higher mean SOD activity than the con-
trol group. However, the finding of Tkaczuk-Wlach et al
study was limited by the fact that they used whole semen
sample, because the membrane-bound oxidases or anti-
oxidants associated with cellular debris and/or organelles
can influence activities of antioxidant enzymes such as
SOD and catalase [12].
Immature spermatozoa with abnormal morphology and
cytoplasmic retention are the most sources of ROS pro-
duction in semen. This has been confirmed by Gil-Guz-
man et al study [36]. Their study showed that there is a
direct significant correlation between ROS levels and the
rate of abnormal forms in semen. Gil-Guzman et al also
observed that there is an inverse significant correlation
between seminal plasma TAC and ROS levels. They sug-
gested that the inverse correlation between TAC and ROS
might be associated with an increase in the consumption
Table 1: Seminal parameters in controls and subgroups of patients.
Diagnosis Concentration (106/ml) Motility (%) Morphology (%)
Controls
Normozoospermic (n = 16) 97.06 ± 5.38 57.81 ± 1.39 39.62 ± 1.04
Patients
Asthenozoospermic (n = 15) 62.40 ± 1.90 46.0 7 ± 0.30 31.07 ± 0.25
Asthenoteratozoospermic (n = 16) 39.00 ± 2.75 36.75 ± 1.38 23.56 ± 0.89
Oligoasthenoteratozoospermic (n = 15) 13.73 ± 1.19 18.53 ± 1.28 16.80 ± 0.33
Data are reported as mean ± SEM.
Table 2: Seminal plasma levels of free 8-Isoprostane and total 
antioxidant capacity (TAC) and activities of catalase and 
superoxide dismutase (SOD) in controls and total patients.
Variables Controls (N = 16) Patients (N = 46)
TAC (mM) 1.63 ± 0.08 1.05 ± 0.04a
Catalase (U/ml) 22.58 ± 2.20 14.40 ± 0.93b
SOD (U/ml) 5.89 ± 0.96 5.32 ± 0.56
8-Isoprostane (ng/ml) 2.60 ± 0.38 18.23 ± 3.56c
Data are reported as mean ± SEM.
ap = 0.001, bp = 0.0.03, cp = 0.0001 in comparison with controls.Page 4 of 6
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which is resulted from over production of ROS. In our
study the correlation between TAC and sperm morphol-
ogy was positive. According to Gil-Guzman et al study,
this finding could be interpreted that in semen with high
rate of abnormal forms, because of high levels of ROS pro-
duction, consumption of non-enzymatic antioxidants will
be higher.
The inverse correlation between lipid peroxidation and
sperm motility has been shown by Keskes-Ammar et al
[24]. In our study both TAC and catalase, two defenses
against ROS, showed direct correlation with sperm motil-
ity. Keskes-Ammar et al and our study might suggest that
the higher level of antioxidant status prevents lipid perox-
idation in spermatozoa and therefore results in higher
sperm motility. Hsieh et al observed a slightly positive cor-
relation between seminal plasma SOD activity and sperm
concentration [14]. Their interpretation was that higher
concentrations of spermatozoa might produce higher lev-
els of SOD. The positive significant correlation between
seminal plasma catalase activity and sperm concentration
that observed in our study may be interpreted similar to
Hsieh et al. Immature spermatozoa generate primary
superoxide anion. This anion is dismuted to hydrogen
peroxide by SOD activity. Detoxification of hydrogen per-
oxide is carried out by catalase activity. Hydrogen perox-
ide is the primary toxic ROS for human spermatozoa that
its high concentration induces lipid peroxidation and
results in cell death. Therefore, the balance of the SOD
and catalase activities in semen is important for maintain-
ing sperm motility [14].
Our results are agreed with some previous studies that
show increasing of lipid peroxidation by measuring MDA
in sperm and seminal plasma in males with astheno-
zoospermia, asthenoteratozoospermia and oligoasthe-
noteratozoospemia [20,23]. Similar to MDA [18,24] 8-
Isoprostane also showed an inverese correlation with
sperm motility.
MDA is widely used index of lipid peroxidation due to its
simplicity. The TBARS test application to body fluids and
tissue samples is unreliable. Application of a gas chroma-
tography/mass spectrometry (GC/MS) assay for MDA has
indicated that the commonly used TBARS assay overesti-
mates the actual MDA levels by more than 10-fold, possi-
bly resulting from cross reactivity with other aldehydes
and the harsh conditions used in sample preparation [26].
Recent studies have focused on 8-Isoprostane, as an index
of lipid peroxidation. Isoprostanes are formed in situ in
cell membranes; following free radical attack on the ara-
chidonic acid. Unlike prostaglandins, which are formed
from arachidonic acid following its release from the sn-2
position of phospholipids by phospholipase A2, isopros-
tanes are formed initially in situ, where they may contrib-
ute to the effects of oxidative stress on membrane
biophysics. Measurement of 8-Isoprostane may provide a
reliable marker of lipid peroxidation in vivo, because, it is
a stable compound. In addition, 8-Isoprostane is specific
product of free radical-induced lipid peroxidation. 8-Iso-
prostane has also been found to be present in detectable
quantities in all normal biological tissues and in free form
in all normal biological fluids. This is important because
it allows the definition of a normal range such that small
increases in its formation can be detected in situations of
mild oxidant stress. Finally, the levels of 8-Isoprostane is
unaffected by lipid content of the diet [26,28].
Evidence is beginning to emerge suggesting that isopros-
tanes are not only markers of oxidative injury, but active
participants in the pathophysiology of some disorders.
The capacity of isoprostanes to readily esterify to cell lipid
membranes, and the resulting marked distortion of mem-
brane structure and function, undoubtedly contribute to
their pathophysiologic potential. As well, the existence of
specific receptor for isoprostanes has been proven [37].
So, because isoprostanes are biologically active, they may
have significant role in the etiology of some sperm func-
tion abnormality.
Table 3: Seminal plasma levels of free 8-Isoprostane and total antioxidant capacity (TAC) and activities of catalase and superoxide 
dismutase (SOD) in controls and subgroups of patients.
Diagnosis 8-Isoprostane (ng/ml) TAC (mM) Catalase (U/ml) SOD (U/ml)
Controls
Normozoospermic (n = 16) 6.95 ± 2.10 1.63 ± 0.08 22.58 ± 2.20 5.89 ± 0.96
Patients
Asthenozoospermic (n = 15) 14.66 ± 4.10a 1.12 ± 0.06d 13.76 ± 1.64e 4.82 ± 0.54
Asthenoteratozoospermic (n = 16) 16.71 ± 5.58b 1.02 ± 0.08d 16.66 ± 1.46f 6.24 ± 1.50
Oligoasthenoteratozoospermic (n = 15) 23.42 ± 8.36c 1.01 ± 0.09d 12.61 ± 1.65g 4.82 ± 0.39
Data are reported as mean ± SEM.
ap = 0.01, bp = 0.008, cp = 0.04, dp = 0.0001, ep = 0.004, fp = 0.04, gp = 0.001 in comparison with normozoospermic men.Page 5 of 6
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It is concluded that decreasing seminal plasma antioxi-
dant status, especially catalase activity and TAC, may have
significant role in the etiology of impaired sperm func-
tion. Measurement of 8-Isoprostane may be used as a spe-
cific biomarker for assessing oxidative stress on sperm.
However, further studies with a larger sample size are
required to confirm these findings.
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